
1,300 Dead in Outbreak; Cyclospora Response 'Mismanaged'? GLP-1 Access in Medicaid
• MannKind announced that the FDA has approved Furoscix ReadyFlow, an autoinjector form of the diuretic furosemide designed to provide IV-equivalent therapy for adults with chronic kidney disease or heart failure. • Merck agreed to permit the production of generics for alimatravir, an investigational once-monthly HIV pre-exposure prophylaxis pill, specifically for low-income nations that approve the drug. • Dr. Craig Spencer argued in The Atlantic that public health strategies should incorporate elements from the "Make America Healthy Again" movement to improve outcomes.
Read story




